Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

R-DHAP Immunochemotherapy Is An Effective Remission-Induction Treatment For CLL Patients With Fludarabine Refractory Disease With Or Without Deletion 17p, Enabling The Majority To Proceed To Allogeneic Stem Cell Transplantation

Michel Van Gelder, PhD, MD, Wendim Ghidey, Martine ED Chamuleau, MD, Jan Cornelissen, MD, PhD, Eefke J Petersen, MD PhD, Simon M. G. J. Daenen, Pierre Zachee, MD, PhD, Mels Hoogendoorn, MD, PhD, Aart Beker, MD, Gert Jan Timmers, MD, PhD, Arnon P. Kater, MD PhD, Marinus H.J. Van Oers, MD, PhD

Blood (2013) 122 (21): 2883.

https://doi.org/10.1182/blood.V122.21.2883.2883

Published: 2013

Journal Articles

The Broad Kinase Inhibitor Dasatinib in Combination with Fludarabine in Patients with Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase 2 Study

Arnon P. Kater, MD PhD, Marjolijn Spiering, Rob D Liu, Marielle M Beckers, Sanne H. Tonino, Simon M. G. J. Daenen, Jeanette K Doorduijn, Nienke A Lankheet, Dieuwertje M Luijks, Doreen te Raa, MD, Eric Eldering, PhD, Marinus H.J. Van Oers, MD, PhD

Blood (2012) 120 (21): 1798.

https://doi.org/10.1182/blood.V120.21.1798.1798

Published: 2012

Journal Articles

Identification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells

Szabolcs Fatrai, Albertus T. J. Wierenga, Simon M. G. J. Daenen, Edo Vellenga, Jan Jacob Schuringa

Blood (2011) 117 (12): 3320–3330.

https://doi.org/10.1182/blood-2010-08-303669

Published: 2011

Includes: Supplemental data

Journal Articles

Treatment of Older Patients, 40 to 70 Years of Age, with Acute Lymphoblastic Leukemia According to a Chemotherapy Regimen That Includes a Novel Pre-Phase for Rapid Tumor Load Reduction. Results of the Dutch-Belgian HOVON-71 Study.

Simon M. G. J. Daenen, Bronno van der Holt, Adriaan W. Dekker, Roelof Willemze, Anita Rijneveld, Bart J. Biemond, Petra Muus, Arjan A van de Loosdrecht, Harry Schouten, M. van Marwijk Kooy, Dimitri Breems, Johan Maertens, Hilde Demuynck, Pierre W Wijermans, Shulamiet Wittebol, Ellen W. de Klerk, Jan J. Cornelissen

Blood (2009) 114 (22): 2028.

https://doi.org/10.1182/blood.V114.22.2028.2028

Published: 2009

Journal Articles

Identification of Human Hematopoietic Stem Cell-Specific STAT5 Target Genes Involved in Self-Renewal and Transformation.

Szabolcs Fatrai, Albertus T.J. Wierenga, Edo Vellenga, Simon M. G. J. Daenen, Jan Jacob Schuringa

Blood (2009) 114 (22): 568.

https://doi.org/10.1182/blood.V114.22.568.568

Published: 2009

Journal Articles

Overexpression of Oncogenic KRAS G12V in Human Stem and Progenitor Cells Enhances Proliferation and Initiates Monocytic Differentiation Via Intrinsic and Extrinsic Pathways.

Szabolcs Fatrai, Djoke van Gosliga, Lina Han, Simon M. G. J. Daenen, Edo Vellenga, Jan Jacob Schuringa

Blood (2009) 114 (22): 3975.

https://doi.org/10.1182/blood.V114.22.3975.3975

Published: 2009

Journal Articles

Raf-1 Is Over Expressed in Chronic Lymphocytic Leukemia and Promotes Cell Survival by Phosphorylation of ERK and BAD

Miao Wang, P.M. Kluin, MD, PhD, Stefano Rosati, Marjan Luinge, Simon M. G. J. Daenen, Sr., Lydia Visser

Blood (2008) 112 (11): 3120.

https://doi.org/10.1182/blood.V112.11.3120.3120

Published: 2008

Journal Articles

Hematopoietic Stem Cells, but Not Progenitors, Are the Exclusive Target for STAT5-Induced Long-Term Self-Renewal.

Szabolcs Fatrai, Albertus T.J. Wierenga, Edo Vellenga, Simon M. G. J. Daenen, Jan J. Schuringa

Blood (2008) 112 (11): 1347.

https://doi.org/10.1182/blood.V112.11.1347.1347

Published: 2008

Journal Articles

The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

Gert J. Ossenkoppele, Wilfried J. Graveland, Pieter Sonneveld, Simon M. G. J. Daenen, Douwe H. Biesma, Leo F. Verdonck, M. Ron Schaafsma, Petra H. M. Westveer, Godefridus J. Peters, Paul Noordhuis, Petra Muus, Dominik Selleslag, Bronnie van der Holt, Michel Delforge, Bob Löwenberg, Gregor E. G. Verhoef, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

Blood (2004) 103 (8): 2908–2913.

https://doi.org/10.1182/blood-2003-07-2195

Published: 2004

NARROW

R-DHAP Immunochemotherapy Is An Effective Remission-Induction Treatment For CLL Patients With Fludarabine Refractory Disease With Or Without Deletion 17p, Enabling The Majority To Proceed To Allogeneic Stem Cell Transplantation

The Broad Kinase Inhibitor Dasatinib in Combination with Fludarabine in Patients with Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase 2 Study

Identification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells

Treatment of Older Patients, 40 to 70 Years of Age, with Acute Lymphoblastic Leukemia According to a Chemotherapy Regimen That Includes a Novel Pre-Phase for Rapid Tumor Load Reduction. Results of the Dutch-Belgian HOVON-71 Study.

Identification of Human Hematopoietic Stem Cell-Specific STAT5 Target Genes Involved in Self-Renewal and Transformation.

Overexpression of Oncogenic KRAS G12V in Human Stem and Progenitor Cells Enhances Proliferation and Initiates Monocytic Differentiation Via Intrinsic and Extrinsic Pathways.

Raf-1 Is Over Expressed in Chronic Lymphocytic Leukemia and Promotes Cell Survival by Phosphorylation of ERK and BAD

Hematopoietic Stem Cells, but Not Progenitors, Are the Exclusive Target for STAT5-Induced Long-Term Self-Renewal.

The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only